Director at Aramark (NYSE: ARMK) awarded 5,124 stock units

Rhea-AI Filing Summary

Aramark director Kenneth M. Keverian reported an equity award of 5,124 deferred stock units on February 3, 2026. The units are tied to Aramark common stock at a reference price of $38.06 per share.

After this grant, he beneficially owns 28,992.516 shares directly. According to the terms, the deferred stock units will vest on the day before the first annual stockholders' meeting after the grant date, assuming continued board service. If vested, they will be settled in shares of common stock on the first day of the seventh month after he leaves the board.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KEVERIAN KENNETH M

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/03/2026		A		5,124(1)	A	$38.06	28,992.516	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	02/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Aramark (ARMK) director Kenneth M. Keverian report?

Kenneth M. Keverian reported receiving 5,124 deferred stock units tied to Aramark common stock. The grant occurred on February 3, 2026, at a reference price of $38.06 per share, increasing his directly beneficially owned holdings to 28,992.516 shares after the transaction.

How many Aramark shares does Kenneth M. Keverian beneficially own after this Form 4?

After the reported transaction, Kenneth M. Keverian beneficially owns 28,992.516 Aramark common shares directly. This reflects the addition of 5,124 deferred stock units granted on February 3, 2026, which are linked to Aramark common stock and reported as an acquisition.

What are the vesting terms of the 5,124 deferred stock units granted to the Aramark director?

The 5,124 deferred stock units vest on the day before the first annual stockholders' meeting occurring after the grant date, subject to continued service. If vested, they will be settled in shares of Aramark common stock on the first day of the seventh month after the director leaves the board.

Is the reported Aramark insider transaction a purchase or an award of stock units?

The reported transaction is an award of deferred stock units, coded as an acquisition (A) on Form 4. It represents 5,124 units linked to Aramark common stock at $38.06 per share, granted as director compensation rather than an open-market stock purchase.

What role does Kenneth M. Keverian hold at Aramark in this Form 4 filing?

In this Form 4 filing, Kenneth M. Keverian is identified as a director of Aramark. The reported transaction reflects a grant of 5,124 deferred stock units related to his board service, with vesting tied to future annual stockholders' meetings and his continued service as a director.

How and when will Kenneth M. Keverian’s Aramark deferred stock units be settled?

If the vesting conditions are met, the deferred stock units will be settled in shares of Aramark common stock. Settlement occurs on the first day of the seventh month after the date of the director’s departure from the board, according to the disclosed terms.